Literature DB >> 3116324

Lupus anticoagulant associated syndrome in benign and malignant systemic disease.

U Dührsen1, D Paar, G Brittinger.   

Abstract

A strong correlation exists between the presence of an in vitro plasma coagulation inhibitor, named "lupus anticoagulant", and a clinical syndrome of recurrent arterial and venous thromboses, neurological abnormalities, repeated obstetrical complications, thrombocytopenia, a biologic false-positive serological test for syphilis, and a variety of rarer manifestations. This syndrome has predominantly been observed in patients with autoimmune diseases, but it may be of similar importance in association with monoclonal gammopathies. As an introduction to a detailed analysis of ten observations which will also be published in this journal, this article reviews the clinical findings, the proposed pathogenetic mechanisms and the approaches to management of the lupus anticoagulant associated syndrome.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3116324     DOI: 10.1007/bf01727476

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  39 in total

1.  Macroglobulinaemia; effect of macroglobulins on prothrombin conversion accelerators.

Authors:  L A LONG; J L RIOPELLE; M FRANCOEUR; A PARE; P POIRIER; M GEORGESCO; G COLPRON
Journal:  Can Med Assoc J       Date:  1955-11-01       Impact factor: 8.262

2.  Lupus anticoagulant, thrombosis, and fetal loss.

Authors:  D I Feinstein
Journal:  N Engl J Med       Date:  1985-11-21       Impact factor: 91.245

3.  Lupus anticoagulants and thrombosis. A study of 25 cases and review of the literature.

Authors:  K Lechner; I Pabinger-Fasching
Journal:  Haemostasis       Date:  1985

4.  Immunologic and coagulation disorders in chlorpromazine-treated patients.

Authors:  M H Zarrabi; S Zucker; F Miller; R M Derman; G S Romano; J A Hartnett; A O Varma
Journal:  Ann Intern Med       Date:  1979-08       Impact factor: 25.391

5.  Thrombosis, abortion, cerebral disease, and the lupus anticoagulant.

Authors:  G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-15

6.  Lupus anticoagulant associated syndrome in benign and malignant systemic disease--analysis of ten observations.

Authors:  U Dührsen; D Paar; C Kölbel; A Boekstegers; U Metz-Kurschel; R Wagner; W Kirch; P Meusers; E König; G Brittinger
Journal:  Klin Wochenschr       Date:  1987-09-15

7.  Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody.

Authors:  E N Harris; R A Asherson; A E Gharavi; S H Morgan; G Derue; G R Hughes
Journal:  Br J Haematol       Date:  1985-02       Impact factor: 6.998

8.  Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant.

Authors:  M L Boey; C B Colaco; A E Gharavi; K B Elkon; S Loizou; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-08

9.  Thromboembolism in patients with the 'lupus'-type circulating anticoagulant.

Authors:  M Elias; A Eldor
Journal:  Arch Intern Med       Date:  1984-03

10.  The lupus anticoagulant.

Authors:  M Boxer; L Ellman; A Carvalho
Journal:  Arthritis Rheum       Date:  1976 Nov-Dec
View more
  1 in total

1.  Lupus anticoagulant associated syndrome in benign and malignant systemic disease--analysis of ten observations.

Authors:  U Dührsen; D Paar; C Kölbel; A Boekstegers; U Metz-Kurschel; R Wagner; W Kirch; P Meusers; E König; G Brittinger
Journal:  Klin Wochenschr       Date:  1987-09-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.